Cma Microdialysis AB
Country not established
- Devices
- 4
What Cma Microdialysis AB makes
Cma Microdialysis AB manufactures the CMA Cerebral Tissue Monitoring System, a device designed for real-time measurement of biochemical markers in brain tissue to assess metabolic conditions such as hypoxia, ischemia, or edema. Modifications to this system are also part of the portfolio, likely involving updates to sensor technology or software for enhanced monitoring capabilities.
The company’s devices are classified as Class II under FDA regulations and are recorded in the 510(k) premarket notification database. The portfolio is regulated in the United States, where the manufacturer is based.
Catalogue
Cma Cerebral Tissue Monitoring System Ref K020285
Regimes: 510(k) Registry: 510(k)- Regimes: 510(k) Registry: 510(k)
Cma Cerebral Tissue Monitoring System Ref K060554
Regimes: 510(k) Registry: 510(k)- Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Cma Microdialysis AB have in the registry?
The registry currently lists 4 devices for Cma Microdialysis AB. Devices recorded under merged duplicate company entries are counted once.
Which registries list Cma Microdialysis AB's devices?
Among its 4 most recently registered devices, Cma Microdialysis AB has devices listed in FDA 510(k) (4 devices).
What risk classes do Cma Microdialysis AB's devices fall under?
Among its 4 most recently registered devices, the classes recorded for Cma Microdialysis AB's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Cma Microdialysis AB in the registry?
The most recently registered devices listed for Cma Microdialysis AB include CMA CEREBRAL TISSUE MONITORING SYSTEM and MODIFICATION TO CMA CEREBRAL TISSUE MONITORING SYSTEM.